Heart Test Laboratories
HSCS
10 hedge funds and large institutions have $232K invested in Heart Test Laboratories in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.01% less ownership
Funds ownership: 0.06% → 0.05% (-0.01%)
57% less capital invested
Capital invested by funds: $545K → $232K (-$313K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ASW
Astoria Strategic Wealth
Conroe,
Texas
|
+$45.2K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$32.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$23.7K |
| 4 |
VF
Virtu Financial
New York
|
+$19.9K |
| 5 |
HF
HRT Financial
New York
|
+$6.13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$78K |
| 2 |
OLVIG
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
|
-$33.6K |
| 3 |
Renaissance Technologies
New York
|
-$32K |
| 4 |
AWM
AE Wealth Management
Topeka,
Kansas
|
-$31.9K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$15.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TWM
1
Tradition Wealth Management
Edina,
Minnesota
| $64K | – | – | – |
|
|
ASW
2
Astoria Strategic Wealth
Conroe,
Texas
| $34.9K | +$45.2K | +583 | +246% |
|
|
OLVIG
3
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
| $29.7K | -$33.6K | -433 | -38% |
|
|
AWM
4
AE Wealth Management
Topeka,
Kansas
| $29.7K | -$31.9K | -411 | -37% |
|
|
CD
5
Chapin Davis
Baltimore,
Maryland
| $23.4K | – | – | – |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $18.3K | +$32.8K | +423 | New |
|
|
7
Citadel Advisors
Miami,
Florida
| $13.2K | +$23.7K | +306 | New |
|
|
VF
8
Virtu Financial
New York
| $11K | +$19.9K | +256 | New |
|
|
HF
9
HRT Financial
New York
| $8K | +$6.13K | +79 | +66% |
|
10
Wells Fargo
San Francisco,
California
| $24 | +$78 | +1 | New |
|
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$78K | -860 | Closed |
|
|
12
Renaissance Technologies
New York
| – | -$32K | -354 | Closed |
|
|
TSS
13
Two Sigma Securities
New York
| – | -$15.8K | -174 | Closed |
|
|
TRCT
14
Tower Research Capital (TRC)
New York
| – | -$812 | -9 | Closed |
|
HSCS Hedge Fund Activity: Q3 2023 in Review
10 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q3 2023, worth a combined $232K — down 57% from $545K a quarter earlier.
Fund positioning in HSCS was balanced in Q3 2023: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Astoria Strategic Wealth, adding an estimated $45.2K. The largest seller was Royal Bank of Canada, exiting entirely with an estimated $78K sold.
- 10 institutional investors held Heart Test Laboratories (HSCS) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $232K of Heart Test Laboratories stock for Q3 2023, down 57% quarter-over-quarter.
- 4 funds opened new Heart Test Laboratories positions in Q3 2023 and 4 closed out, a net change of 0 holders.
- The largest Heart Test Laboratories buyer in Q3 2023 was Astoria Strategic Wealth, an estimated $45.2K added.
- The largest Heart Test Laboratories seller in Q3 2023 was Royal Bank of Canada, an estimated $78K sold.
Based on aggregated 13F filings for Q3 2023.